June 17, 2020 / 8:41 PM / 25 days ago

BRIEF-Eyepoint Pharmaceuticals Got Letter From Nasdaq As Co Didn't Meet Minimum Price For Continued Listing - SEC Filing

June 17 (Reuters) - EyePoint Pharmaceuticals Inc:

* EYEPOINT PHARMACEUTICALS - GOT LETTER FROM NASDAQ CO DIDN'T MEET MINIMUM PRICE FOR CONTINUED LISTING - SEC FILING Source text: bit.ly/2URUIKa Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below